Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

IMUX

IMUX News

Newswire

04:06

Immunic Inc's Vidofludimus Calcium Holds Promise for Treating Multiple Sclerosis

06:34

Immunic CEO to Participate in Fireside Chat at Evercore ISI Healthcare Conference.

09:31

Immunic Advances Vidofludimus Calcium Therapy for Multiple Sclerosis with Promising Q3 Results

08:18

Immunic: HC Wainwright Keeps Buy Rating, Lowers PT to $8 from $10.

12:16

Immunic's Vidofludimus Calcium Advances in MS Treatment: Q3 Highlights and Upcoming Milestones

View More

About IMUX

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More